Vaxcyte PCVX
NASDAQ PCVX
$56.69 -1.58 (-2.71%)
At close: Sep 29, 2026 · 4:00 PM EDT

Vaxcyte (PCVX) Operating Expenses (2019 - 2026)

Updated

Vaxcyte's Operating Expenses was $302.78 million in Q2 2026, up 33.8% from $226.22 million a year earlier but down 12.5% from the prior quarter.

Analysis

Vaxcyte (PCVX) Operating Expenses (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vaxcyte's Operating Expenses was $1.17 billion through Jun 30, 2026, up 64.3% year-over-year; for FY2025, it was $923.68 million, up 62.2% from FY2024.

  • Operating Expenses has now increased for seven consecutive years, with a five-year compound annual growth rate of 59.5% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $569.55 million in FY2024 (+21.7%), $468.04 million in FY2023 (+101.5%), $232.26 million in FY2022 (+124.0%) and $103.67 million in FY2021 (+15.7%).
  • Quarterly Operating Expenses has moved between $26.95 million (Q3 2021) and $345.85 million (Q1 2026) over five years.
  • Compared with a year earlier, Operating Expenses has increased for six straight quarters, with growth averaging 47.4% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q4 2022 (growth of 190.1%); the worst was Q4 2024 (a decline of 17.5%).
  • Per Business Quant data, PCVX's Operating Expenses in the three quarters before Q2 2026 was $345.85 million (Q1 2026), $274.28 million (Q4 2025) and $242.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Vaxcyte 8.44 Bn 8.44 Bn - 302.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 302.78 Mn
Mar 31, 2026 345.85 Mn
Dec 31, 2025 274.28 Mn
Sep 30, 2025 242.38 Mn
Jun 30, 2025 226.22 Mn
Mar 31, 2025 180.79 Mn
Dec 31, 2024 162.17 Mn
Sep 30, 2024 139.92 Mn
Jun 30, 2024 152.98 Mn
Mar 31, 2024 114.47 Mn
Dec 31, 2023 196.68 Mn
Sep 30, 2023 113.03 Mn
Jun 30, 2023 87.15 Mn
Mar 31, 2023 71.19 Mn
Dec 31, 2022 86.57 Mn
Sep 30, 2022 58.58 Mn
Jun 30, 2022 47.89 Mn
Mar 31, 2022 39.22 Mn
Dec 31, 2021 29.85 Mn
Sep 30, 2021 26.95 Mn
API Access

Vaxcyte Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=PCVX&period=max&api_key=YOUR_API_KEY